Quilter 13F: Adds $2M to Stryker (SYK) Stake

Quilter increased its position in Stryker Corporation SYK by 7.7%, adding 7,250 shares to hold 101,298 shares worth about $27.9 million. The adjustment appeared in a Form 13F filing with the U.S. Securities and Exchange Commission on October 21, 2026.

SYK Stryker Corporation

$297.60 ▼ -13.79% year to date

1M 3M YTD

Daily close · Oct 21, 2026

What Changed in Quilter's Stryker Corporation Position

Prior to this filing, the fund owned 94,048 shares of the medical technology company. The 7.7% increase lifted the total holding past the 100,000-share mark, reflecting a larger allocation to the healthcare stock during the reported period.

Other Institutional Activity in Stryker Corporation

Greenleaf Trust reduced its holdings by 709,231 shares, ending with 15,228,545 shares worth about $4,532,015,084 in data covering the period up to June 30, 2026.

Stryker Corporation Stock Down 0.4%

Stryker Corporation recently traded around $297.63 as of October 22, 2026, compared to an event close of $297.60 on October 21, 2026. The stock sits near its 50-day moving average of $297.28, while trading below its 200-day moving average of $325.90. Shares have moved between a 52-week low of $267.00 and a 52-week high of $392.55.

Recent Earnings

Stryker Corporation generated $25,837,000,704 in trailing-twelve-month revenue alongside earnings of $9.65 per share. The company reported a net profit margin of 14.4% and a return on equity of 16.5%. The next earnings report is scheduled for October 29, 2026.

Dividend

Stryker Corporation pays an annual dividend rate of $3.52 per share, yielding 1.18% with a payout ratio of 36.1%.

Insider Buying and Selling at Stryker Corporation

Insider activity leading up to the filing included multiple sales by officers and directors. On May 28, 2026, officer Robert S Fletcher parted with 4,544 shares valued at $1,394,409. Later, on August 18, 2026, officer Debra King sold 826 shares at $336.30 each for a total of $277,787. Director Ronda E Stryker disposed of 350,000 shares on August 19, 2026, worth $117,776,128. Finally, officer Dylan Bram Crotty sold 441 shares on August 21, 2026, at $328.60 apiece, totaling $144,915.

Analysts Set New Price Targets

Analyst coverage ahead of the filing showed a mix of rating actions. On September 22, 2026, TD Cowen maintained a hold rating and lowered its price target from $355.00 to $298.00. Stifel kept a buy rating on September 30, 2026, adjusting its target from $360.00 to $330.00. Truist Securities maintained a hold rating on October 7, 2026, reducing its target from $340.00 to $310.00. On the same day, Barclays initiated coverage with an overweight rating and a $375.00 price target. BTIG maintained a buy rating on October 12, 2026, moving its target from $358.00 to $316.00. Overall, the stock carries a consensus buy recommendation from 26 analysts, with a mean price target of $362.62.

About Stryker Corporation

Stryker Corporation develops and sells medical technology products globally. It operates through segments focused on MedSurg, Neurotechnology, and Orthopaedics, providing hospitals and clinics with surgical equipment, neurovascular devices, and joint replacement implants.

Bottom Line

Investors are keeping an eye on the upcoming earnings report on October 29, 2026, to gauge operational momentum across the company's major segments. Further institutional filings will reveal whether other large asset managers followed Quilter's lead in adjusting their stakes.